From a toxicological perspective, individuals with MCADD are at increased risk for adverse reactions to certain drugs and environmental chemicals that affect metabolic pathways. For example, substances that inhibit fatty acid oxidation or exacerbate hypoglycemia can be particularly dangerous. Toxicologists must consider these risks when evaluating exposure and recommending treatments.
